Revolution Medicines Stock Performance
| RVMD Stock | USD 102.61 0.78 0.77% |
On a scale of 0 to 100, Revolution Medicines holds a performance score of 9. The company holds a Beta of -0.17, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Revolution Medicines are expected to decrease at a much lower rate. During the bear market, Revolution Medicines is likely to outperform the market. Please check Revolution Medicines' kurtosis, and the relationship between the downside variance and day median price , to make a quick decision on whether Revolution Medicines' historical price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.89) | Five Day Return 5.2 | Year To Date Return 28.87 | Ten Year Return 252.35 | All Time Return 252.35 |
1 | Disposition of 3104 shares by Jack Anders of Revolution Medicines at 77.0904 subject to Rule 16b-3 | 12/16/2025 |
2 | Disposition of 51406 shares by Horn Margaret A of Revolution Medicines at 42.45 subject to Rule 16b-3 | 01/02/2026 |
3 | Disposition of 908 shares by Cislini Jeff of Revolution Medicines at 115.6 subject to Rule 16b-3 | 01/21/2026 |
4 | Merck Ends Acquisition Talks With Revolution Medicines After Valuation Dispute | 01/26/2026 |
5 | Revolution Medicines Dives 16.9 percent as Merck Withdraws Takeover Plan | 01/27/2026 |
6 | Universal Beteiligungs und Servicegesellschaft mbH Has 3.68 Million Stock Holdings in Revolution Medicines, Inc. RVMD | 01/29/2026 |
7 | Revolution Medicines to Participate in Guggenheim Securities Emerging Outlook Biotech Summit 2026 | 02/04/2026 |
8 | A Look At Revolution Medicines Valuation After First Patient Dosed In RMC-5127 Trial | 02/06/2026 |
9 | Candriam S.C.A. Grows Holdings in Revolution Medicines, Inc. RVMD | 02/09/2026 |
10 | Profund Advisors LLC Acquires 6,585 Shares of Revolution Medicines, Inc. RVMD | 02/10/2026 |
11 | NEOS Investment Management LLC Acquires 32,694 Shares of Revolution Medicines, Inc. RVMD | 02/19/2026 |
12 | Disposition of 10000 shares by Jack Anders of Revolution Medicines at 98.0 subject to Rule 16b-3 | 02/20/2026 |
| Begin Period Cash Flow | 696.1 M | |
| Total Cashflows From Investing Activities | -554.4 M |
Revolution | Build AI portfolio with Revolution Stock |
Revolution Medicines Relative Risk vs. Return Landscape
If you would invest 7,632 in Revolution Medicines on November 25, 2025 and sell it today you would earn a total of 2,551 from holding Revolution Medicines or generate 33.43% return on investment over 90 days. Revolution Medicines is currently generating 0.5877% in daily expected returns and assumes 4.8094% risk (volatility on return distribution) over the 90 days horizon. In different words, 43% of stocks are less volatile than Revolution, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Revolution Medicines Target Price Odds to finish over Current Price
The tendency of Revolution Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 102.61 | 90 days | 102.61 | about 22.02 |
Based on a normal probability distribution, the odds of Revolution Medicines to move above the current price in 90 days from now is about 22.02 (This Revolution Medicines probability density function shows the probability of Revolution Stock to fall within a particular range of prices over 90 days) .
Revolution Medicines Price Density |
| Price |
Predictive Modules for Revolution Medicines
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Revolution Medicines. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Revolution Medicines Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Revolution Medicines is not an exception. The market had few large corrections towards the Revolution Medicines' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Revolution Medicines, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Revolution Medicines within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.72 | |
β | Beta against Dow Jones | -0.17 | |
σ | Overall volatility | 16.03 | |
Ir | Information ratio | 0.14 |
Revolution Medicines Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Revolution Medicines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Revolution Medicines can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Revolution Medicines appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (600.09 M) with loss before overhead, payroll, taxes, and interest of (880.48 M). | |
| Revolution Medicines currently holds about 461.43 M in cash with (557.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.26. | |
| Revolution Medicines has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: NEOS Investment Management LLC Acquires 32,694 Shares of Revolution Medicines, Inc. RVMD |
Revolution Medicines Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Revolution Stock often depends not only on the future outlook of the current and potential Revolution Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Revolution Medicines' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 167.7 M | |
| Cash And Short Term Investments | 2.3 B |
Revolution Medicines Fundamentals Growth
Revolution Stock prices reflect investors' perceptions of the future prospects and financial health of Revolution Medicines, and Revolution Medicines fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Revolution Stock performance.
| Return On Equity | -0.61 | ||||
| Return On Asset | -0.32 | ||||
| Current Valuation | 6.54 B | ||||
| Shares Outstanding | 193.32 M | ||||
| Price To Book | 4.58 X | ||||
| Price To Sales | 9,035 X | ||||
| Gross Profit | (880.48 M) | ||||
| EBITDA | (677.7 M) | ||||
| Net Income | (600.09 M) | ||||
| Cash And Equivalents | 461.43 M | ||||
| Cash Per Share | 5.26 X | ||||
| Total Debt | 135.84 M | ||||
| Debt To Equity | 0.13 % | ||||
| Current Ratio | 7.60 X | ||||
| Book Value Per Share | 8.42 X | ||||
| Cash Flow From Operations | (557.44 M) | ||||
| Earnings Per Share | (5.19) X | ||||
| Market Capitalization | 19.69 B | ||||
| Total Asset | 2.56 B | ||||
| Retained Earnings | (1.74 B) | ||||
| Working Capital | 2.16 B | ||||
About Revolution Medicines Performance
By analyzing Revolution Medicines' fundamental ratios, stakeholders can gain valuable insights into Revolution Medicines' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Revolution Medicines has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Revolution Medicines has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.22) | (0.23) | |
| Return On Capital Employed | (0.26) | (0.27) | |
| Return On Assets | (0.21) | (0.22) | |
| Return On Equity | (0.24) | (0.25) |
Things to note about Revolution Medicines performance evaluation
Checking the ongoing alerts about Revolution Medicines for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Revolution Medicines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Revolution Medicines appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (600.09 M) with loss before overhead, payroll, taxes, and interest of (880.48 M). | |
| Revolution Medicines currently holds about 461.43 M in cash with (557.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.26. | |
| Revolution Medicines has a frail financial position based on the latest SEC disclosures | |
| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: NEOS Investment Management LLC Acquires 32,694 Shares of Revolution Medicines, Inc. RVMD |
- Analyzing Revolution Medicines' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Revolution Medicines' stock is overvalued or undervalued compared to its peers.
- Examining Revolution Medicines' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Revolution Medicines' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Revolution Medicines' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Revolution Medicines' stock. These opinions can provide insight into Revolution Medicines' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Revolution Stock analysis
When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |